Symrise AG (DE:SY1)
XETRA:SY1
Want to see DE:SY1 full AI Analyst Report?
Top Page
Symrise
(XETRA:SY1)
Select Model
Select Model
Rating:58Neutral
Price Target:
€75.00
▼(-2.85% Downside)
Action:Reiterated
Date:03/07/26
The score is primarily held back by 2025 profitability and growth weakening (lower margins and ROE, slightly negative revenue growth) and a mixed-to-weak technical picture (below key moving averages). These are partly offset by a generally stable financial base (consistent free cash flow and manageable leverage), but the high P/E and modest yield weigh on valuation support.
Positive Factors
Diversified, market-leading franchise
Symrise's multi-segment model (Flavor, Fragrance, Nutrition, Cosmetic Ingredients) serves food, personal care and household end markets. This diversification reduces exposure to a single cycle, sustains recurring B2B revenues and leverages scale for R&D and customer intimacy, supporting durable competitive advantage.
Negative Factors
Material margin compression
A sharp step-down in operating and net margins in 2025 materially reduces cash generation per euro of sales. If driven by secular cost pressures, pricing limits or mix shifts, lower margins erode capacity to fund innovation and returns, and could persistently weaken profitability and strategic flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified, market-leading franchise
Symrise's multi-segment model (Flavor, Fragrance, Nutrition, Cosmetic Ingredients) serves food, personal care and household end markets. This diversification reduces exposure to a single cycle, sustains recurring B2B revenues and leverages scale for R&D and customer intimacy, supporting durable competitive advantage.
Read all positive factors
Symrise (SY1) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€10.31B
Dividend Yield1.75%
Average Volume (3M)411.29K
Price to Earnings (P/E)―
Beta (1Y)0.57
Revenue Growth-1.39%
EPS Growth-47.86%
CountryDE
Employees12,385
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)1.78
Shares Outstanding139,772,050
10 Day Avg. Volume376,730
30 Day Avg. Volume411,288
Financial Highlights & Ratios
PEG Ratio-0.81
Price to Book (P/B)2.59
Price to Sales (P/S)1.96
P/FCF Ratio18.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€84.37Price Target Upside9.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)3.8
Revenue Forecast (FY)€4.97B
Symrise Business Overview & Revenue Model
Company Description
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides fu...
How the Company Makes Money
Symrise generates revenue primarily through the sale of its flavor and fragrance products across various markets. The company operates a multi-segment revenue model, with key revenue streams derived from its Flavor, Fragrance, Nutrition, and Cosme...
Symrise Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.93B | 5.00B | 4.73B | 4.62B | 3.83B |
| Gross Profit | 1.85B | 1.96B | 1.69B | 1.70B | 1.48B |
| EBITDA | 907.87M | 1.04B | 841.49M | 780.50M | 806.40M |
| Net Income | 249.30M | 478.20M | 340.47M | 280.01M | 374.92M |
Balance Sheet | |||||
| Total Assets | 8.11B | 8.32B | 7.85B | 7.78B | 6.64B |
| Cash, Cash Equivalents and Short-Term Investments | 1.01B | 709.49M | 393.03M | 314.86M | 465.14M |
| Total Debt | 2.61B | 2.55B | 2.56B | 2.55B | 1.80B |
| Total Liabilities | 4.36B | 4.31B | 4.16B | 4.17B | 3.39B |
| Stockholders Equity | 3.72B | 3.98B | 3.63B | 3.55B | 3.19B |
Cash Flow | |||||
| Free Cash Flow | 521.05M | 667.49M | 449.31M | 109.94M | 347.40M |
| Operating Cash Flow | 717.82M | 894.91M | 719.51M | 360.11M | 521.56M |
| Investing Cash Flow | -310.51M | -291.51M | -358.29M | -984.84M | -713.60M |
| Financing Cash Flow | -78.31M | -281.88M | -264.22M | 481.52M | -92.15M |
Symrise Technical Analysis
Positive
77.20
Price Trends
73.62
Positive
71.87
Positive
75.67
Positive
Market Momentum
0.66
Negative
63.29
Neutral
88.84
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:SY1, the sentiment is Positive. The current price of 77.2 is above the 20-day moving average (MA) of 72.72, above the 50-day MA of 73.62, and above the 200-day MA of 75.67, indicating a bullish trend. The MACD of 0.66 indicates Negative momentum. The RSI at 63.29 is Neutral, neither overbought nor oversold. The STOCH value of 88.84 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:SY1.
Symrise Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | €8.30B | 15.61 | 1.89% | 8.92% | -9.37% | -47.49% | |
63 Neutral | €8.87B | 21.10 | 5.27% | 4.30% | -9.48% | -56.88% | |
58 Neutral | €10.31B | -124.46 | 9.75% | 1.75% | -1.39% | -47.86% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €4.93B | 100.12 | -20.12% | 3.75% | ― | ― | |
49 Neutral | €1.60B | -2.86 | -17.77% | 0.59% | -14.31% | -386.04% | |
45 Neutral | €12.42B | -7.53 | -10.04% | ― | -8.72% | -140.66% |
* General Sector Average
DE:SY1
Symrise
73.76
-27.65
-27.26%
DE:BNR
Brenntag AG
61.40
3.53
6.09%
DE:1COV
Covestro
59.80
-0.62
-1.03%
DE:EVK
Evonik
17.81
-1.23
-6.45%
DE:LXS
LANXESS
18.55
-8.55
-31.54%
DE:WCH
Wacker Chemie AG
99.20
35.05
54.64%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.